# Florey Biosciences, Inc. — Form D

Florey Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-29. The offering totals $4.4M, of which $1.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-04-29
- Form: D
- Accession: 0002066011-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.4M
- Amount sold: $1.4M
- Remaining: $3.0M
- Investors: 1
- Date of first sale: 2025-04-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-544696

## Issuer

- Name: Florey Biosciences, Inc.
- CIK: 0002066011
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 160 ALEWIFE BROOK PKWY #1378, CAMBRIDGE, MA, 02138
- Phone: 603-306-1237

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Andres Fernando Cubillos Ruiz | Director | Cambridge, MA |
| Peter Fernando Hutt | Director | Cambridge, MA |
| Mark Fernando Smith | Director | Cambridge, MA |
| Andres Fernando Cubillos Ruiz | Executive Officer | Cambridge, MA |
| Raphael Fernando Gayet | Executive Officer | Cambridge, MA |

## More

- [CIK 2066011 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2066011&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002066011-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.